MACC1 overexpression and survival in solid tumors: a meta-analysis

Tumor Biology

Volumn 36, Issue 2, 2015, Pages 1055-1065

  Wang, Gang ^a   Fu, Zhixuan ^a   Li, Dechuan ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

MACC1; Meta analysis; Prognosis

Indexed keywords

METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; MACC1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; GENE OVEREXPRESSION; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LUNG CANCER; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; META ANALYSIS; PATHOLOGY; PROGNOSIS; RECTUM TUMOR; TUMOR RECURRENCE;

DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECTAL NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84925521617     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2736-9     Document Type: Article

References (36)

1. Kokoszynska K, Krynski J, Rychlewski L, Wyrwicz LS. Unexpected domain composition of MACC1 links met signaling and apoptosis. Acta Biochim Pol. 2009;56:317–23.
2. Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, et al. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One. 2012;7:e49249.
3. Kawamura M, Saigusa S, Toiyama Y, Tanaka K, Okugawa Y, Hiro J, et al. Correlation of MACC1 and met expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res. 2012;32:1527–31.
4. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15:59–67.
5. Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, et al. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg. 2012;256:763–71. discussion 771.
6. Isella C, Mellano A, Galimi F, Petti C, Capussotti L, De Simone M, et al. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg. 2013;257:1089–95.
7. Ge SH, Wu XJ, Wang XH, Xing XF, Zhang LH, Zhu YB, et al. Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients. Chin J Cancer Res. 2011;23:153–9.
8. Guo T, Yang J, Yao J, Zhang Y, Da M, Duan Y. Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int. 2013;13:121.
9. Wang L, Wu Y, Lin L, Liu P, Huang H, Liao W, et al. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer. 2013;133:1419–30.
10. Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, et al. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 2012;18:2995–3003.
11. Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z, et al. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One. 2013;8:e64235.
12. Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL, Dong Z, et al. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med. 2013;11:41.
13. Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li C, et al. MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma. Asian Pac J Cancer Prev. 2014;15:999–1003.
14. Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, et al. Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int J Med Sci. 2014;11:268–75.
15. Chundong G, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res. 2011;31:1141–5.
16. Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L, et al. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol. 2014;31:790.
17. Zhu M, Xu Y, Mao X, Gao Y, Shao L, Yan F. Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer. Pathol Oncol Res. 2013;19:749–53.
18. Zhang K, Zhang Y, Zhu H, Xue N, Liu J, Shan C, Zhu Q, et al. High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumour Biol 2014;35:1343-50.
19. Yang T, Kong B, Kuang YQ, Cheng L, Gu JW, Zhang JH, et al. Overexpression of MACC1 protein and its clinical implications in patients with glioma. Tumour Biol. 2014;35:815–9.
20. Hagemann C, Fuchs S, Monoranu CM, Herrmann P, Smith J, Hohmann T, et al. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. Neurol Oncol. 2013;15:1696–709.
21. Wang Y, Hong Q, Wang J, Fang Y, Hu C. Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion. Tumour Biol. 2014;35:3771–8.
22. Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye C, et al. Overexpression of macc1 and its significance in human breast cancer progression. Cell Biosci. 2013;3:16.
23. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000
24. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–34.
25. Handoll HH. Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil. 2006;87:875.
26. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ Br Med J. 2007;335:914.
27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.
28. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
29. Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol. 2009;41:2356–9.
30. Canadas I, Taus A, Gonzalez I, Villanueva X, Gimeno J, Pijuan L, et al. High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients. Oncotarget. 2014;5:5246–56.
31. Zhang K, Tian F, Zhang Y, Zhu Q, Xue N, Zhu H, Wang H, Guo X, et al. MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol 2014;35:2537-48.
32. Wang G, Kang MX, Lu WJ, Chen Y, Zhang B, Wu YL. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett. 2012;4:783–91.
33. Meng F, Li H, Shi H, Yang Q, Zhang F, Yang Y, et al. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS One. 2013;8:e60821.
34. Zhang K, Tian F, Zhang Y, Zhu Q, Xue N, Zhu H, et al. MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol. 2014;35:2537–48.
35. Ocana A, Vera-Badillo F, Seruga B, Templeton A, Pandiella A, Amir E. Her3 overexpression and survival in solid tumors: a meta-analysis. J Natl Cancer Inst. 2013;105:266–73.
36. Pichorner A, Sack U, Kobelt D, Kelch I, Arlt F, Smith J, et al. In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice. Clin Exp Metastasis. 2012;29:573–83.